ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase

September 30, 1983

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

NCI Advisory Group, Other Cancer Meetings

February 24, 1989

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

8 Pittsburg Employees Started Coalition That Lasted 8 Days

June 10, 1994